Scientific papers

Please use the menu on the right to browse publications by year, cancer type or author, or enter a search term in the box below.

Displaying 21 - 28 of 28 papers
Click here to reset all search parameters [1]

Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology [2]

Sharp L, Cotton SC, Thornton A, Gray N, Cruickshank M, Whynes D, Duncan I, Hammond R, Smart L, Little J, on behalf of the TOMBOLA Group.

Eur J Obstet Gynecol Reprod Biol. 2012;165(2):318-25.
'It's a can of worms': understanding primary care practitioners' behaviours in relation to HPV using the theoretical domains framework [3]

McSherry LA, Dombrowski SU, Francis JJ, Murphy J, Martin CM, O'Leary JJ, Sharp L for the ATHENS group.

Implement Sci. 2012;7:73.
Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial [4]

Sharp L, Cotton S, Thornton A, Gray N, Whynes D, Smart L, Waugh N, Duncan I, Cruickshank M, Little J, on behalf of the TOMBOLA Group.

Cytopathology. 2012;23(3):150-60.
After-effects reported by women having follow-up cervical cytology tests in primary care: a cohort study within the TOMBOLA trial [5]

Cotton S, Sharp L, Cochran C, Gray N, Cruickshank ME, Smart L, Thornton A, Little J on behalf of the TOMBOLA Group.

Br J Gen Pract. 2011;61(587):333-9.
Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status [6]

Johnson CY, Sharp L, Cotton SC, Harris CA, Gray NM, Little J, on behalf of the TOMBOLA Group .

PLOS ONE. 2011;6(6):e21046.
Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for coloposcopy: a randomised controlled trial [7]

Sharp L, Cotton S, Gray N, Avis M, Russell I, Walker L, Waugh N, Whynes D, Woolley C, Thornton A, Smart L, Cruickshank M, Little J, on behalf of the TOMBOLA Group.

Br J Cancer. 2011;104(2):255-64.
Mortality predictions for Ireland, 2001-2015: cancers of the breast, ovary, and cervix and corpus uteri [8]

O'Lorcain P, Comber H.

Int J Gynecol Cancer. 2006;16(S1):1-10.
Recent trends in cervical cancer mortality in Britain and Ireland: the case for population-based cervical cancer screening [9]

Comber H, Gavin A.

Br J Cancer. 2004;91(11):1902-4.

Pages

[12]

[13]